Paul W. Spearman
Experienced in Common Cold

Dr. Paul W. Spearman

Pediatric Infectious Disease | Infectious Disease
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Accepting New Patients
Experienced in Common Cold
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical Research

Overview

Paul Spearman is a Pediatric Infectious Disease specialist and an Infectious Disease provider in Cincinnati, Ohio. Dr. Spearman is rated as an Experienced provider by MediFind in the treatment of Common Cold. His top areas of expertise are HIV/AIDS, Flu, Parainfluenza, and Severe Acute Respiratory Syndrome (SARS). Dr. Spearman is currently accepting new patients.

His clinical research consists of co-authoring 96 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Common Cold.

Specialties
Pediatric Infectious Disease
Infectious Disease
Licenses
Internal Medicine in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medical Health
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

CHILDREN'S HOSPITAL MEDICAL CENTER
3333 Burnet Ave, Cincinnati, OH 45229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation Phase 1b Study to Evaluate the Safety and Immunogenicity of an Intranasal Live Attenuated Respiratory Syncytial Virus (RSV) Vaccine in Seropositive Young Children
A Randomized, Single-Blind, Placebo-Controlled, Dose-Escalation Phase 1b Study to Evaluate the Safety and Immunogenicity of an Intranasal Live Attenuated Respiratory Syncytial Virus (RSV) Vaccine in Seropositive Young Children
Enrollment Status: Completed
Publish Date: June 29, 2021
Intervention Type: Other, Biological
Study Phase: Phase 1

96 Total Publications

Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.
Safety and immunogenicity of intranasal parainfluenza virus type 5 (PIV5)-vectored COVID-19 vaccine in adults and teens in an open-label phase 1 trial.
Journal: Science advances
Published: July 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Spearman's expertise for a condition
ConditionClose
      View All 11 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile